Synthesis and asymmetric resolution of a dopaminergic compound: 2-amino-5-methoxyindane

被引:2
作者
Akbaba, Yusuf [1 ,2 ]
Goksu, Suleyman [1 ]
Sahin, Ertan [1 ]
Kilic, Hamdullah [1 ]
Secen, Hasan [1 ]
机构
[1] Ataturk Univ, Dept Chem, Fac Sci, Erzurum, Turkey
[2] Erzurum Tech Univ, Dept Basic Sci, Fac Sci, Erzurum, Turkey
关键词
DERIVATIVES; ACID;
D O I
10.1016/j.tetasy.2016.04.005
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The racemic synthesis and subsequent resolution of 2-amino-5-methoxyindane enantiomers were achieved starting from 5-bromoindan-2-ol in six steps with 38% total yield. The first step involved the substitution of the Br atom by using NaOMe in the presence of CuI to afford 5-methoxyindan-2-ol. The OH group of 5-methoxyindan-2-ol was converted into its mesylate ester, which was converted into the corresponding azide by reaction with sodium azide. The Pd C-catalyzed hydrogenation of the azide functional group in the presence of CHCI3, followed by neutralization of the amine hydrochloride salt with NaOH, furnished the rac-2-amino-5-methoxyindane. Next, rac-2-amino-5-methoxyindane was converted into its diastereomeric amide derivatives by reaction with (R)-mandeloyl chloride. The diastereomeric amide mixture was separated by recrystallization to give the (R,S)- and (R,R)-diastereomers. The absolute configuration of the (R,S)-isomer was determined by X-ray crystallography. The hydrolysis of these diastereomers gave (R)- and (S)-2-amino-5-methoxyindane with high enantiopurity. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:475 / 479
页数:5
相关论文
共 24 条
  • [1] ABEL MS, 1978, PHARMACOLOGIST, V20, P241
  • [2] BERLINGOZZI S, 1954, GAZZ CHIM ITAL, V84, P383
  • [3] Cannon J G, 1985, Prog Drug Res, V29, P303
  • [4] CEREBRAL DOPAMINE AGONIST PROPERTIES OF SOME 2-AMINOTETRALIN DERIVATIVES AFTER PERIPHERAL AND INTRACEREBRAL ADMINISTRATION
    CANNON, JG
    LEE, T
    GOLDMAN, HD
    COSTALL, B
    NAYLOR, RJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (09) : 1111 - 1116
  • [5] Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole
    Giladi, Nir
    Boroojerdi, Babak
    Korczyn, Amos D.
    Burn, David J.
    Clarke, Carl E.
    Schapira, Anthony Hn.
    [J]. MOVEMENT DISORDERS, 2007, 22 (16) : 2398 - 2404
  • [6] Gillen K. J., 2010, PCT Int. Appl., Patent No. [153, 2010115952A1, 20101014, 2010115952, WO 2,010,115,952 Al 20101014]
  • [7] An alternative synthesis of the dopaminergic drug 2-amino-1,2,3,4-tetrahydronaphthalene-5,6-diol (5,6-ADTN)
    Göksu, S
    Seçen, H
    Sütbeyaz, Y
    [J]. HELVETICA CHIMICA ACTA, 2006, 89 (02) : 270 - 273
  • [8] Concise syntheses of 2-aminoindans via indan-2-ol
    Göksu, S
    Seçen, H
    [J]. TETRAHEDRON, 2005, 61 (28) : 6801 - 6807
  • [9] Göksu S, 2005, TURK J CHEM, V29, P199
  • [10] Haadsma-svensson S. R., 1995, PCT Int. Appl., Patent No. [9504713, WO 9,504,713 Al 19950216]